Cited by 215Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismAdrenal Hormones and Disorders

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Overexpression of 11β-Hydroxysteroid Dehydrogenase-1 in Adipose Tissue Is Associated with Acquired Obesity and Features of Insulin Resistance: Studies in Young Adult Monozygotic Twins

Kannisto, Katja, Pietiläinen, Kirsi H., Ehrenborg, Ewa, Rissanen, Aila, Kaprio, Jaakko, Hamsten, Anders, Yki-Järvinen, Hannele·2004·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2004-0153

Open this paper in CoChat — free account

Abstract

11beta-Hydroxysteroid dehydrogenase type 1 (11beta-HSD-1) catalyzes the interconversion of inactive cortisone to active cortisol. Overexpression of 11beta-HSD-1 in murine adipose tissue results in glucocorticoid receptor (GR)alpha overexpression, central obesity, and insulin resistance. It is controversial whether 11beta-HSD-1 or GRalpha expression are increased in human adipose tissue in obesity. We studied effects of acquired obesity on 11beta-HSD-1 gene (real-time PCR) and protein (Western blotting) expression in sc adipose tissue in 17 monozygotic twin pairs aged 24-27 yr with a mean intrapair difference in body mass index (BMI) of 3.8 kg/m(2) (range 0.4-10.1 kg/m(2)). Intrapair correlations were calculated to study effects of acquired obesity on 11beta-HSD-1 expression. Western blot analysis of adipose tissue homogenates identified approximately 50- and approximately 68-kDa proteins specific for 11beta-HSD-1. Both structural forms correlated positively with 11beta-HSD-1 mRNA concentrations. Intrapair differences in 11beta-HSD-1 mRNA, and the 50- and 68-kDa proteins in sc adipose tissue correlated positively with those in BMI (kilograms per square meter) (r = 0.78 for 11beta-HSD-1 mRNA, P = 0.0002; r = 0.87 for the 11beta-HSD-1 50-kDa protein, P = 0.0003; and r = 0.62 for the 11beta-HSD-1 68-kDa protein, P = 0.033), total body fat (percent) (r = 0.65, P = 0.005; r = 0.83, P = 0.001; and r = 0.69, P = 0.013, respectively) and sc fat (cubed centimeters) (r = 0.66, P = 0.004; r = 0.94, P = 0.0001; and r = 0.71, P = 0.009, respectively). Furthermore, 11beta-HSD-1 mRNA and 50-kDa protein expression, but not 68-kDa protein expression, correlated positively with intrapair differences in intraabdominal fat mass (cubed centimeters) (r = 0.62, P = 0.008; r = 0.69, P = 0.013; r = 0.48, P = 0.112) and serum fasting insulin concentration (milliunits per liter) (r = 0.76, P = 0.0004; r = 0.60, P = 0.037; and r = 0.43, P = 0.160, respectively). Intrapair differences in GRalpha expression were significantly inversely correlated with those in BMI and total and sc fat mass. In conclusion, expression of 11beta-HSD-1 in sc adipose tissue is increased in human acquired obesity and is closely related to accumulation of sc and intraabdominal fat and features of insulin resistance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1210/jc.2004-0153

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,218
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition
Mazess, R., Barden, H. S., Bisek, J., & Hanson, J. (1990) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.6.1106 · Cited by 1,465
Use of Polyethylene Glycol to Separate Free and Antibody-Bound Peptide Hormones in Radioimmunoassays†
Desbuquois, B., & Aurbach, G. D. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-5-732 · Cited by 1,295
Classical twin studies and beyond
Boomsma, D., Busjahn, A., & Peltonen, L. (2002) · Nature Reviews Genetics · doi:10.1038/nrg932 · Cited by 1,105
11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress
Kotelevtsev, Y. V., Holmes, M. C., Burchell, A. N., Houston, P., Schmoll, D., Jamieson, P. M., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 863
Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
Vidal‐Puig, A., Considine, R. V., Jimenez‐Liñan, M., Werman, A., Pories, W. J., Caro, J. F., & Flier, J. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119424 · Cited by 785
Does central obesity reflect “Cushing's disease of the omentum”?
Bujalska, I. J., Kumar, S., & Stewart, P. M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11222-8 · Cited by 753

Show all 45 references

Sorted by citations

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Pathophysiology of human visceral obesity: an update
Tchernof, A., & Després, J.-P. (2013) · Physiological Reviews · doi:10.1152/physrev.00033.2011 · Cited by 2,583
Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity
Bays, H. E., González-Campoy, J. M., Bray, G. A., Kitabchi, A. E., Bergman, D. A., Schorr, A. B., Rodbard, H. W., & Henry, R. R. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.3.343 · Cited by 543
Glucocorticoids and cardiovascular disease
Walker, B. R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0455 · Cited by 529
Correlation of Obesity and Osteoporosis: Effect of Fat Mass on the Determination of Osteoporosis
Zhao, L., Jiang, H., Papasian, C. J., Maulik, D., Drees, B. M., Hamilton, J., & Deng, H. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070813 · Cited by 529
Free fatty acids and insulin resistance
Delarue, J., & Magnan, C. (2007) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328042ba90 · Cited by 478
Diagnosis and management of the metabolic syndrome
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000200416.65370.a0 · Cited by 437
Hypothalamic-pituitary-adrenal axis dysregulation and cortisol activity in obesity: A systematic review
Rodriguez, A. C. I., Epel, E. S., White, M. L., Standen, E. C., Seckl, J. R., & Tomiyama, A. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.014 · Cited by 452
Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects – A Monozygotic Twin Study
Pietiläinen, K. H., Sysi‐Aho, M., Rissanen, A., Seppänen‐Laakso, T., Yki‐Järvinen, H., Kaprio, J. A., & Orešič, M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000218 · Cited by 418
Self-citation
Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385
Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity
Lee, M., Pramyothin, P., Karastergiou, K., & Fried, S. K. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.029 · Cited by 399
The 11-β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
Rosenstock, J., Banarer, S., Fonseca, V. A., Inzucchi, S. E., Sun, W. Y., Yao, W., Hollis, G. F., Flores, R., Levy, R., Williams, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2315 · Cited by 315
Global Transcript Profiles of Fat in Monozygotic Twins Discordant for BMI: Pathways behind Acquired Obesity
Pietiläinen, K. H., Naukkarinen, J., Rissanen, A., Saharinen, J., Ellonen, P., Keränen, H., Suomalainen, A., Götz, A., Suortti, T., Yki‐Järvinen, H., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050051 · Cited by 303
Self-citation
Treatment of type 2 diabetes: challenges, hopes, and anticipated successes
Nauck, M. A., Wefers, J., & Meier, J. J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00113-3 · Cited by 315
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
Wang, M. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-3 · Cited by 284
The adipocyte as an active participant in energy balance and metabolism
Badman, M. K., & Flier, J. S. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.058 · Cited by 256
Adipocyte-Specific Glucocorticoid Inactivation Protects Against Diet-Induced Obesity
Kershaw, E. E., Morton, N. M., Dhillon, H., Ramage, L. E., Seckl, J. R., & Flier, J. S. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1023 · Cited by 253
Association of Lipidome Remodeling in the Adipocyte Membrane with Acquired Obesity in Humans
Pietiläinen, K. H., Róg, T., Seppänen‐Laakso, T., Virtue, S., Gopalacharyulu, P. V., Tang, J. P., Rodríguez‐Cuenca, S., Maciejewski, A., Naukkarinen, J., Ruskeepää, A., et al. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1000623 · Cited by 242
Self-citation
Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
Kaserer, T., Beck, K. R., Akram, M., Odermatt, A., & Schuster, D. (2015) · Molecules · doi:10.3390/molecules201219880 · Cited by 214
Increased In Vivo Regeneration of Cortisol in Adipose Tissue in Human Obesity and Effects of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Carbenoxolone
Sandeep, T. C., Andrew, R., Homer, N. Z. M., Andrews, R. C., Smith, K., & Walker, B. R. (2005) · Diabetes · doi:10.2337/diabetes.54.3.872 · Cited by 203
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196
11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation
Cooper, M. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1412 · Cited by 183
Cortisol—cause and cure for metabolic syndrome?
Walker, B. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01998.x · Cited by 179
Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease
Morton, N. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 169
Inhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Wamil, M., & Seckl, J. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.001 · Cited by 163
Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism
Qi, D., & Rodrigues, B. B. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00453.2006 · Cited by 162
Early life programming of obesity and metabolic disease
Cottrell, E. C., & Ozanne, S. E. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.017 · Cited by 158
Tissue Production of Cortisol by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Metabolic Disease
Walker, B. R., & Andrew, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.012 · Cited by 151
Androgen metabolism in adipose tissue: Recent advances
Blouin, K., Veilleux, A., Luu-The, V., & Tchernof, A. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.035 · Cited by 147
Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: A study in monozygotic and dizygotic twins
Makkonen, J., Pietiläinen, K. H., Rissanen, A., Kaprio, J. A., & Yki‐Järvinen, H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.025 · Cited by 145
Self-citation
11&Bgr;-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Morton, N. M., & Seckl, J. R. (2008) · KARGER eBooks · doi:10.1159/000115363 · Cited by 132
Deep Subcutaneous Adipose Tissue: A Distinct Abdominal Adipose Depot
Walker, G. E., Verti, B., Marzullo, P., Savia, G., Mencarelli, M., Zurleni, F., Liuzzi, A., & Blasio, A. M. D. (2007) · Obesity · doi:10.1038/oby.2007.231 · Cited by 129
Twin Studies in Finland 2006
Kaprio, J. A. (2006) · Twin Research and Human Genetics · doi:10.1375/183242706779462778 · Cited by 123
Self-citation
The role of sex steroids in white adipose tissue adipocyte function
Newell‐Fugate, A. E. (2017) · Reproduction · doi:10.1530/rep-16-0417 · Cited by 117
The Discovery of New 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors by Common Feature Pharmacophore Modeling and Virtual Screening
Schuster, D., Maurer, E. M., Laggner, C., Nashev, L. G., Wilckens, T., Langer, T., & Odermatt, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600794 · Cited by 110
Modulation of glucocorticoid metabolism by the growth hormone – IGF‐1 axis
Agha, A., & Monson, J. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02763.x · Cited by 108
11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
Anagnostis, P. G., Katsiki, N., Adamidou, F., Athyros, V. G., Karagiannis, A. I., Kita, M. D., & Mikhailidis, D. P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.002 · Cited by 107
Adiposopathy: how do diet, exercise and weight loss drug therapies improve metabolic disease in overweight patients?
Bays, H. E., Blonde, L., & Rosenson, R. S. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.871 · Cited by 103
Omental 11β‐hydroxysteroid Dehydrogenase 1 Correlates with Fat Cell Size Independently of Obesity
Michailidou, Z., Jensen, M. D., Dumesic, D. A., Chapman, K. E., Seckl, J. R., Walker, B. R., & Morton, N. M. (2007) · Obesity · doi:10.1038/oby.2007.618 · Cited by 102
11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity
Hughes, K. A., Webster, S. P., & Walker, B. R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.481 · Cited by 102
The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
Napoli, N., Strollo, R., Paladini, A., Briganti, S., Pozzilli, P., & Epstein, S. (2014) · International Journal of Endocrinology · doi:10.1155/2014/690783 · Cited by 105
The Contribution of Visceral Adipose Tissue to Splanchnic Cortisol Production in Healthy Humans
Andrew, R., Westerbacka, J., Wahren, J., Yki‐Järvinen, H., & Walker, B. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1364 · Cited by 98
Self-citation
Causes and consequences of obesity: the contribution of recent twin studies
Naukkarinen, J., Rissanen, A., Kaprio, J. A., & Pietiläinen, K. H. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.192 · Cited by 110
Self-citation
The Pharmacophore Concept and Its Applications in Computer-Aided Drug Design
Seidel, T., Schuetz, D. A., Garon, A., & Langer, T. (2019) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-030-14632-0_4 · Cited by 90
Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue
Apostolova, G., Schweizer, R. A. S., Balázs, Z., Kostadinova, R. M., & Odermatt, A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00442.2004 · Cited by 87
Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments
Pietiläinen, K. H., Korkeila, M., Bogl, L. H., Westerterp, K. R., Yki‐Järvinen, H., Kaprio, J. A., & Rissanen, A. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.251 · Cited by 87
Self-citation
Acquired obesity and poor physical fitness impair expression of genes of mitochondrial oxidative phosphorylation in monozygotic twins discordant for obesity
Mustelin, L., Pietiläinen, K. H., Rissanen, A., Sovijärvi, A. R., Piirilä, P., Naukkarinen, J., Peltonen, L., Kaprio, J., & Yki-Järvinen, H. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00580.2007 · Cited by 85
Self-citation
Postnatal Programming of Glucocorticoid Metabolism in Rats Modulates High-Fat Diet–Induced Regulation of Visceral Adipose Tissue Glucocorticoid Exposure and Sensitivity and Adiponectin and Proinflammatory Adipokines Gene Expression in Adulthood
Boullu‐Ciocca, S., Achard, V., Tassistro, V., Dutour, A., & Grino, M. (2007) · Diabetes · doi:10.2337/db07-1316 · Cited by 84
Discovery of a Potent, Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor for Clinical Study: Identification of (S)-2-((1S,2S,4R)-Bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221)
Véniant, M. M., Hale, C., Hungate, R. W., Gahm, K. H., Emery, M. G., Jona, J. A., Joseph, S., Adams, J., Hague, A. B., Moniz, G. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100242d · Cited by 81
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 82
Glucocorticoid Regulation of the Promoter of 11β-Hydroxysteroid Dehydrogenase Type 1 Is Indirect and Requires CCAAT/Enhancer-Binding Protein-β
Sai, S., Esteves, C. L., Kelly, V., Michailidou, Z., Anderson, K., Coll, A. P., Nakagawa, Y., Ohzeki, T., Seckl, J. R., & Chapman, K. E. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0489 · Cited by 81
Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
Rohde, J. J., Pliushchev, M. A., Sorensen, B. K., Wódka, D., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Pan, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609364 · Cited by 78
Omental Adipose Tissue Type 1 11β-Hydroxysteroid Dehydrogenase Oxoreductase Activity, Body Fat Distribution, and Metabolic Alterations in Women
Veilleux, A., Rhéaume, C., Daris, M., Luu-The, V., & Tchernof, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2011 · Cited by 77
Comparative enzymology of 11β-hydroxysteroid dehydrogenase type 1 from six species
Arampatzis, S., Kadereit, B., Schuster, D., Balázs, Z., Schweizer, R. A. S., Frey, F. J., Langer, T., & Odermatt, A. (2005) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01736 · Cited by 75
Adipose tissue 11β-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing’s syndrome
Mariniello, B., Ronconi, V., Rilli, S., Bernante, P., Boscaro, M., Mantero, F., & Giacchetti, G. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02228 · Cited by 77
Adiposopathy: why do adiposity and obesity cause metabolic disease?
Bays, H. E., & Ballantyne, C. M. (2006) · Future Lipidology · doi:10.2217/17460875.1.4.389 · Cited by 75
Disruption of glucocorticoid action by environmental chemicals: Potential mechanisms and relevance
Odermatt, A., Gumy, C., Atanasov, A. G., & Dzyakanchuk, A. A. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.010 · Cited by 74
Identification of differentially expressed genes in fibroblasts derived from patients with Dupuytren's Contracture
Satish, L., LaFramboise, W. A., O’Gorman, D. B., Johnson, S. L., Janto, B., Gan, B. S., Baratz, M. E., Hu, F. Z., Post, J. C., Ehrlich, G. D., et al. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-10 · Cited by 73
Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice
Nuotio-Antar, A. M., Hachey, D. L., & Hasty, A. H. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00522.2007 · Cited by 73
Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
Tomlinson, J., & Stewart, P. M. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0023 · Cited by 73
11 β ‐Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus
Hollis, G. F., & Huber, R. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01305.x · Cited by 72
Acquired Obesity Increases CD68 and Tumor Necrosis Factor-α and Decreases Adiponectin Gene Expression in Adipose Tissue: A Study in Monozygotic Twins
Pietiläinen, K. H., Kannisto, K., Korsheninnikova, E., Rissanen, A., Kaprio, J. A., Ehrenborg, E., Hamsten, A., & Yki‐Järvinen, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2848 · Cited by 72
Self-citation
Prenatal Programming of Metabolic Syndrome in the Common Marmoset Is Associated With Increased Expression of 11β-Hydroxysteroid Dehydrogenase Type 1
Nyirenda, M., Carter, R., Tang, J. I.-S., de Vries, A., Schlumbohm, C., Hillier, S. G., Streit, F., Oellerich, M., Armstrong, V. W., Fuchs, E., et al. (2009) · Diabetes · doi:10.2337/db09-0873 · Cited by 70
Fetal origins of insulin resistance and the metabolic syndrome: A key role for adipose tissue?
Meas, T. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.09.001 · Cited by 69
Type 2 diabetes and metabolic syndrome are associated with increased expression of 11β-hydroxysteroid dehydrogenase 1 in obese subjects
Alberti, L., Girola, A., Gilardini, L., Conti, A., Cattaldo, S., Micheletto, G., & Invitti, C. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803677 · Cited by 69
Overexpression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients
Baudrand, R. F., Carvajal, C. A., Riquelme, A. J., Morales, M., Solı́s, N., Pizarro, M., Escalona, A., Boza, C., Pérez, G., Domínguez, A., et al. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9937-0 · Cited by 68
Methionine restriction effects on 11β-HSD1 activity and lipogenic/lipolytic balance in F344 rat adipose tissue
Perrone, C. E., Mattocks, D. A. L., Hristopoulos, G., Plummer, J. D., Krajcik, R. A., & Orentreich∥, N. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700194-jlr200 · Cited by 70
Glucocorticoid metabolism within superficial subcutaneous rather than visceral adipose tissue is associated with features of the metabolic syndrome in South African women
Goedecke, J. H., Wake, D. J., Levitt, N. S., Lambert, E. V., Collins, M. R., Morton, N. M., Andrew, R., Seckl, J. R., & Walker, B. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02552.x · Cited by 67
Expression of genes related to glucocorticoid action in human subcutaneous and omental adipose tissue
Veilleux, A., Laberge, P. Y., Morency, J., Noël, S., Luu-The, V., & Tchernof, A. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.02.024 · Cited by 64
Novel therapeutics for type 2 diabetes: insulin resistance
Altaf, Q. A., Barnett, A. H., & Tahrani, A. A. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12400 · Cited by 66
Chronic Maternal Dietary Chromium Restriction Modulates Visceral Adiposity
Padmavathi, I. J. N., Rao, K. R., Lagishetty, V., Ganeshan, M., Kumar, K. A., Rao, C. N., Nemani, H., Ismail, A., & Raghunath, M. (2009) · Diabetes · doi:10.2337/db09-0779 · Cited by 63
Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity
Darmon, P., Dadoun, F., Boullu-Ciocca, S., Grino, M., Alessi, M.-C., & Dutour, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00654.2005 · Cited by 59
Mechanisms of disease: regulation of glucocorticoid and receptor levels – impact on the metabolic syndrome
Witchel, S. F., & DeFranco, D. B. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0323 · Cited by 58
Obesity and Type 2 Diabetes Do Not Alter Splanchnic Cortisol Production in Humans
Basu, R., Singh, R., Basu, A., Chittilapilly, E. G., Johnson, M. C., TOFFOLO, G. M., Cobelli, C., & Rizza, R. A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2390 · Cited by 58
Insulin and Dexamethasone Dynamically Regulate Adipocyte 11β-Hydroxysteroid Dehydrogenase Type 1
Balachandran, A., Guan, H., Sellan, M. E., Uum, S. H. M. V., & Yang, K. (2008) · Endocrinology · doi:10.1210/en.2008-0088 · Cited by 57
Acute In Vivo Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity by Insulin and Intralipid Infusions in Humans
Wake, D. J., Homer, N. Z. M., Andrew, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0819 · Cited by 57
Subcutaneous Abdominal Adipose Tissue Subcompartments: Potential Role in Rosiglitazone Effects
Walker, G. E., Marzullo, P., Verti, B., Guzzaloni, G., Maestrini, S., Zurleni, F., Liuzzi, A., & Blasio, A. M. D. (2008) · Obesity · doi:10.1038/oby.2008.326 · Cited by 56
Modulation of glucocorticoid action and the treatment of type-2 diabetes
Tomlinson, J., & Stewart, P. M. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.07.003 · Cited by 56
Acute in vivo effects of insulin on gene expression in adipose tissue in insulin-resistant and insulin-sensitive subjects
Westerbacka, J., Cornér, A., Kannisto, K., Kolak, M., Makkonen, J., Korsheninnikova, E., Nyman, T., Hamsten, A., Fisher, R. M., & Yki‐Järvinen, H. (2005) · Diabetologia · doi:10.1007/s00125-005-0075-5 · Cited by 56
Self-citation
Blockade of Glucocorticoid Excess at the Tissue Level: Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 as a Therapy for Type 2 Diabetes
Fotsch, C. H., & Wang, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800369f · Cited by 55
Dissection of glucocorticoid receptor-mediated inhibition of the hypothalamic–pituitary–adrenal axis by gene targeting in mice
Laryea, G. N., Muglia, L. M., Arnett, M. G., & Muglia, L. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.09.002 · Cited by 57
Extra-adrenal regeneration of glucocorticoids by 11β-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning
Walker, B. R. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s002966510700523x · Cited by 52
11β-HSD1 in Human Fetal Membranes as a Potential Therapeutic Target for Preterm Birth
Wang, W., Chen, Z., Myatt, L., & Sun, K. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00188 · Cited by 50
2-(S)-Phenethylaminothiazolones as Potent, Orally Efficacious Inhibitors of 11β-Hydroxysteriod Dehydrogenase Type 1
Jean, D. J. S., Yuan, C., Bercot, E. A., Cupples, R. L., Chen, M., Fretland, J., Hale, C., Hungate, R. W., Komorowski, R., Véniant, M. M., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061214f · Cited by 50
Tissue Specific Regulation of Glucocorticoids in Severe Obesity and the Response to Significant Weight Loss Following Bariatric Surgery (BARICORT)
Woods, C. P., Corrigan, M., Gathercole, L., TAYLOR, A. E. R., Hughes, B. A., Gaoatswe, G., Manolopoulos, K. N., Hogan, A. E., O’Connell, J., Stewart, P. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4120 · Cited by 49
11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
Morgan, S., & Tomlinson, J. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.504713 · Cited by 47
11β-Hydroxysteroid Dehydrogenase Type 1 Induction in the Arcuate Nucleus by High-Fat Feeding: A Novel Constraint to Hyperphagia?
Densmore, V. S., Morton, N. M., Mullins, J. J., & Seckl, J. R. (2006) · Endocrinology · doi:10.1210/en.2006-0106 · Cited by 47
Increased expression of the macrophage markers and of 11β-HSD-1 in subcutaneous adipose tissue, but not in cultured monocyte-derived macrophages, is associated with liver fat in human obesity
Makkonen, J., Westerbacka, J., Kolak, M., Sutinen, J., Cornér, A., Hamsten, A., Fisher, R. M., & Yki‐Järvinen, H. (2007) · International Journal of Obesity · doi:10.1038/sj.ijo.0803635 · Cited by 45
Self-citation
Preadipocyte 11β-Hydroxysteroid Dehydrogenase Type 1 Is a Keto-Reductase and Contributes to Diet-Induced Visceral Obesity in Vivo
Peixoto, R. D. S., Turban, S., Battle, J. H., Chapman, K. E., Seckl, J. R., & Morton, N. M. (2008) · Endocrinology · doi:10.1210/en.2007-1028 · Cited by 45
Obesity, sleep apnea, aldosterone, and hypertension
Goodfriend, T. L. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0042-x · Cited by 44
Inhibition of 11β-HSD1 as a novel treatment for the metabolic syndrome: do glucocorticoids play a role?
Thieringer, R., & Hermanowski‐Vosatka, A. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.5.911 · Cited by 43
Genetic determinants of cardiometabolic risk: A proposed model for phenotype association and interaction
Blackett, P. R., & Sanghera, D. K. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.04.079 · Cited by 47
The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitors
Yuan, C., Jean, D. J. S., Liu, Q., Cai, L., Li, A., Han, N., Moniz, G. A., Askew, B. C., Hungate, R. W., Johansson, L., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.09.070 · Cited by 41
Essential roles of 11β-HSD1 in regulating brown adipocyte function
Liu, J., Kong, X., Wang, L., Qi, H., Di, W., Zhang, X., Wu, L., Chen, X., Yu, J., Zha, J., et al. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0099 · Cited by 41
Genetic manipulation of 11β-hydroxysteroid dehydrogenases in mice
Paterson, J. M., Seckl, J. R., & Mullins, J. J. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00017.2005 · Cited by 40
11β-Hydroxysteroid Dehydrogenase Types 1 and 2 Activity in Subcutaneous Adipose Tissue in Humans: Implications in Obesity and Diabetes
Dube, S., Norby, B., Pattan, V., Carter, R. E., Basu, A., & Basu, R. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3017 · Cited by 39
11β-HSD1, Inflammation, Metabolic Disease and Age-related Cognitive (dys)Function
Chapman, K. E., & Seckl, J. R. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9504-9 · Cited by 37
Virtual screening applications in short-chain dehydrogenase/reductase research
Beck, K. R., Kaserer, T., Schuster, D., & Odermatt, A. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.008 · Cited by 38
Adipose tissue in cortisol excess: What Cushing’s syndrome can teach us?
Bavaresco, A., Mazzeo, P., Lazzara, M., & Barbot, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116137 · Cited by 41
Cortisol in tissue and systemic level as a contributing factor to the development of metabolic syndrome in severely obese patients
Constantinopoulos, P., Michalaki, M. A., Kottorou, A. E., Habeos, I. G., Psyrogiannis, A. I., Kalfarentzos, F., & Kyriazopoulou, V. E. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0626 · Cited by 35

Authors: Kannisto, K., Pietiläinen, K. H., Ehrenborg, E., Rissanen, A., Kaprio, J., Hamsten, A., & Yki-Järvinen, H.
Affiliations: Karolinska Institutet (SE)
University of Helsinki (FI)
Helsinki University Hospital (FI)
Corresponding author: Kannisto, Katja
ORCID: Pietiläinen, Kirsi H.
Ehrenborg, Ewa
Kaprio, Jaakko
Hamsten, Anders
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2004-09
Volume: 89
Issue: 9
Pages: 4414-4421
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2004-0153
OpenAlex: W2102335700
Cited by: 205
References: 45
Citations by year: 2026: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 6 · 2016: 5 · 2015: 8 · 2014: 11 · 2013: 10 · 2012: 10
FWCI: 17.74
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: Helsingin ja Uudenmaan Sairaanhoitopiiri
European Commission (QLG2-CT-2002-01254, 01254)
Hjärt-Lungfonden
Karolinska Institutet
Stockholms Läns Landsting
Svenska Läkaresällskapet
Medical Research Council
Socialstyrelsen
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords: 11β-hydroxysteroid dehydrogenase type 1, insulin resistance, subcutaneous adipose tissue, monozygotic twins, glucocorticoid receptor alpha, cortisol, body mass index, adipose tissue gene expression, young adults, adipocyte hypertrophy
MeSH terms: Adipose Tissue, Fatty Acids, Nonesterified, Humans, Insulin Resistance, Obesity, Receptors, Glucocorticoid, RNA, Messenger, Twins, Monozygotic, Up-Regulation, Gene Expression Regulation, Enzymologic, 11-beta-Hydroxysteroid Dehydrogenase Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Overexpression of 11β-Hydroxysteroid Dehydrogenase-1 in Adipose Tissue Is Associated with Acquired Obesity and Features of Insulin Resistance: Studies in Young Adult Monozygotic Twins

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks